Cargando…

Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines

Cancer is a leading cause of morbidity and mortality worldwide. Apoptosis is a process of programmed cell death and it plays a vital role in human development and tissue homeostasis. Mounting evidence indicates that apoptosis is closely related to the survival of cancer and it has emerged as a key t...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Weixiao, Lai, Honglin, Zhang, Yangyang, Liu, Minghua, Lin, Xiukun, Cao, Shousong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639427/
https://www.ncbi.nlm.nih.gov/pubmed/31354479
http://dx.doi.org/10.3389/fphar.2019.00758
_version_ 1783436465821188096
author An, Weixiao
Lai, Honglin
Zhang, Yangyang
Liu, Minghua
Lin, Xiukun
Cao, Shousong
author_facet An, Weixiao
Lai, Honglin
Zhang, Yangyang
Liu, Minghua
Lin, Xiukun
Cao, Shousong
author_sort An, Weixiao
collection PubMed
description Cancer is a leading cause of morbidity and mortality worldwide. Apoptosis is a process of programmed cell death and it plays a vital role in human development and tissue homeostasis. Mounting evidence indicates that apoptosis is closely related to the survival of cancer and it has emerged as a key target for the discovery and development of novel anticancer drugs. Various studies indicate that targeting the apoptotic signaling pathway by anticancer drugs is an important mechanism in cancer therapy. Therefore, numerous novel anticancer agents have been discovered and developed from traditional Chinese medicines (TCMs) by targeting the cellular apoptotic pathway of cancer cells and shown clinically beneficial effects in cancer therapy. This review aims to provide a comprehensive discussion for the role, pharmacology, related biology, and possible mechanism(s) of a number of important anticancer TCMs and their derivatives mainly targeting the cellular apoptotic pathway. It may have important clinical implications in cancer therapy.
format Online
Article
Text
id pubmed-6639427
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66394272019-07-26 Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines An, Weixiao Lai, Honglin Zhang, Yangyang Liu, Minghua Lin, Xiukun Cao, Shousong Front Pharmacol Pharmacology Cancer is a leading cause of morbidity and mortality worldwide. Apoptosis is a process of programmed cell death and it plays a vital role in human development and tissue homeostasis. Mounting evidence indicates that apoptosis is closely related to the survival of cancer and it has emerged as a key target for the discovery and development of novel anticancer drugs. Various studies indicate that targeting the apoptotic signaling pathway by anticancer drugs is an important mechanism in cancer therapy. Therefore, numerous novel anticancer agents have been discovered and developed from traditional Chinese medicines (TCMs) by targeting the cellular apoptotic pathway of cancer cells and shown clinically beneficial effects in cancer therapy. This review aims to provide a comprehensive discussion for the role, pharmacology, related biology, and possible mechanism(s) of a number of important anticancer TCMs and their derivatives mainly targeting the cellular apoptotic pathway. It may have important clinical implications in cancer therapy. Frontiers Media S.A. 2019-07-12 /pmc/articles/PMC6639427/ /pubmed/31354479 http://dx.doi.org/10.3389/fphar.2019.00758 Text en Copyright © 2019 An, Lai, Zhang, Liu, Lin and Cao http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
An, Weixiao
Lai, Honglin
Zhang, Yangyang
Liu, Minghua
Lin, Xiukun
Cao, Shousong
Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
title Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
title_full Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
title_fullStr Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
title_full_unstemmed Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
title_short Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
title_sort apoptotic pathway as the therapeutic target for anticancer traditional chinese medicines
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639427/
https://www.ncbi.nlm.nih.gov/pubmed/31354479
http://dx.doi.org/10.3389/fphar.2019.00758
work_keys_str_mv AT anweixiao apoptoticpathwayasthetherapeutictargetforanticancertraditionalchinesemedicines
AT laihonglin apoptoticpathwayasthetherapeutictargetforanticancertraditionalchinesemedicines
AT zhangyangyang apoptoticpathwayasthetherapeutictargetforanticancertraditionalchinesemedicines
AT liuminghua apoptoticpathwayasthetherapeutictargetforanticancertraditionalchinesemedicines
AT linxiukun apoptoticpathwayasthetherapeutictargetforanticancertraditionalchinesemedicines
AT caoshousong apoptoticpathwayasthetherapeutictargetforanticancertraditionalchinesemedicines